Influence of perineurial cells and toll-like receptors 2 and 9 on herpes simplex type 1 entry to the central nervous system in rat encephalitis

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Bereczky Veress, Biborka ^a   Abdelmagid, Nada ^a   Piehl, Fredrik ^a   Bergström, Tomas ^b   Olsson, Tomas ^a   Sköldenberg, Birgit ^a   Diez, Margarita ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; AUTACOID; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; INFECTION SENSITIVITY; MALE; NONHUMAN; PERINEURIUM; PHAGOCYTE; PROTEIN EXPRESSION; RAT; STRAIN DIFFERENCE; TRIGEMINUS GANGLION; VIBRISSA; VIRUS ENTRY; VIRUS IMMUNITY; VIRUS STRAIN; ANIMAL; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; INNERVATION; KINETICS; MACROPHAGE; METABOLISM; NATURAL KILLER CELL; PATHOLOGY; PERIPHERAL NERVE; PHYSIOLOGY; SCHWANN CELL; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TIME; VIROLOGY; VIRUS ENCEPHALITIS;

HERPES; HUMAN HERPESVIRUS 1; RATTUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; DENDRITIC CELLS; ENCEPHALITIS, VIRAL; GENE EXPRESSION REGULATION; HERPESVIRUS 1, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; KILLER CELLS, NATURAL; KINETICS; MACROPHAGES; MALE; PERIPHERAL NERVES; RATS; RNA, MESSENGER; SCHWANN CELLS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9; TRIGEMINAL GANGLION; VIBRISSAE; VIRUS INTERNALIZATION;

EID: 77957893715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012350     Document Type: Article

References (34)

1. Hjalmarsson A, Granath F, Forsgren M, Brytting M, Blomqvist P, et al. (2009) Prognostic value of intrathecal antibody production and DNA viral load in cerebrospinal fluid of patients with herpes simplex encephalitis. J Neurol 256: 1243-1251.
2. Aurelius E, Forsgren M, Sklödenberg B, Strannegard O (1993) Persistent intrathecal immune activation in patients with herpes simplex encephalitis. J Infect Dis 168: 1248-1252.
3. Sköldenberg B, Aurelius E, Hjalmarsson A, Sabri F, Forsgren M, et al. (2006) Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol 253: 163-170.
4. Sato A, Linehan MM, Iwasaki A (2006) Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A 103: 17343-17348.
5. Bereczky-Veress B, Lidman O, Sabri F, Bednar I, Granath F, et al. (2008) Host strain-dependent difference in susceptibility in a rat model of herpes simplex type 1 encephalitis. J Neurovirol 14: 102-118.
6. Wuest TR, Carr DJ (2008) The role of chemokines during herpes simplex virus-1 infection. Front Biosci 13: 4862-4872.
7. Sorensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, et al. (2008) TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol 181: 8604-8612.
8. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, et al. (2003) Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Tolllike receptor 2. J Virol 77: 4588-4596.
9. Boehme KW, Guerrero M, Compton T (2006) Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177: 7094-7102.
10. Goethals S, Ydens E, Timmerman V, Janssens S (2010) Toll-like receptor expression in the peripheral nerve. Glia Article online in advance of print.
11. Bsibsi M, Ravid R, Gveric D, van Noort JM (2002) Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61: 1013-1021.
12. Peltier DC, Simms A, Farmer JR, Miller DJ (2010) Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J Immunol 184: 7010-7021.
13. Krug A, Luker GD, Barchet W, Leib DA, Akira S, et al. (2004) Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103: 1433-1437.
14. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, et al. (2007) The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 177: 265-275.
15. Akashi-Takamura S, Miyake K (2008) TLR accessory molecules. Curr Opin Immunol 20: 420-425.
16. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, et al. (2006) Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency. Science 314: 308-312.
17. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, et al. (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-1527.
18. Mansur DS, Kroon EG, Nogueira ML, Arantes RM, Rodrigues SC, et al. (2005) Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am J Pathol 166: 1419-1426.
19. Sarangi PP, Kim B, Kurt-Jones E, Rouse BT (2007) Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 81: 11128-11138.
20. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
21. Sorkin LS, Xiao WH, Wagner R, Myers RR (1997) Tumour necrosis factoralpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81: 255-262.
22. Bove GM, Weissner W, Barbe MF (2009) Long lasting recruitment of immune cells and altered epi-perineurial thickness in focal nerve inflammation induced by complete Freund's adjuvant. J Neuroimmunol 213: 26-30.
23. Kastrukoff LF, Lau AS, Takei F, Smyth MJ, Jones CM, et al. (2010) Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice. Virology 400: 248-258.
24. Sköldenberg B, Forsgren M, Alestig K, Bergström T, Burman L, et al. (1984) Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet 2: 707-711.
25. Bergström T, Lycke E (1990) Neuroinvasion by herpes simplex virus. An in vitro model for characterization of neurovirulent strains. J Gen Virol 71((Pt 2)): 405-410.
26. Pease PC (1962) Buffered formaldehyde as a killing agent and primary fixative for electron microscopy. Anat Rec 142: 342.
27. Zamboni L, De Martino C (1967) Buffered picric acid formaldehyde. A new rapid fixative for electron microscopy. J Cell Biol 35: 148A.
28. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates: Academic Press.
29. Coons AH (1958) Fluorescent antibody methods. in Danielli, JF General Cytochemical Methods, Academic Press, New York. pp 399-422.
30. Jessen KR, Mirsky R (1984) Nonmyelin-forming Schwann cells coexpress surface proteins and intermediate filaments not found in myelin-forming cells: a study of Ran-2, A5E3 antigen and glial fibrillary acidic protein. J Neurocytol 13: 923-934.
31. Cheng C, Zochodne DW (2002) In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience 115: 321-329.
32. Triolo D, Dina G, Lorenzetti I, Malaguti M, Morana P, et al. (2006) Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci 119: 3981-3993.
33. Smirkin A, Matsumoto H, Takahashi H, Inoue A, Tagawa M, et al. (2010) Iba1(+)/NG2(+) macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J Cereb Blood Flow Metab 30: 603-615.
34. Yamazaki T, Seko Y, Tamatani T, Miyasaka M, Yagita H, et al. (1993) Expression of intercellular adhesion molecule-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol 143: 410-418.